RIVADENEIRA MEDICAL DEVICES
Chile
10 employees
Company description
See translation
Officially launched on the market on August 27, 2019 at Expohospital Santiago de Chile -Chile. It was successfully presented at the medical technology and innovation fair https://www.expohospital.cl/bisturies-ecoamigables-presentara-empresa-chilena/?fbclid=IwAR18jEfRPFPhGPByl5Zliwt5twLsHUpnIGwxS1mjq-ZDmfbNA0Ni0c7 The Biobist-Rivscalpel, patent application in the Institute of Intellectual Property Chile under the international agreement of Paris for 174 nations and www.rivadeneiramd.cl offers private and public health systems a new bet, a turning point in modern surgery , a new device that joins the existing ones to revolutionize the way we carry out surgical procedures and how we are responsible with our planet. For the first time in the history of medicine, we questioned the “status quo” of today's metal surgery teams to create a new line of eco-sustainable surgical equipment, with 100% biosafety in surgical procedures, greatly improving visibility by offering photons at the incision point, which undoubtedly translates into better visual comfort for the physician, nurse and Paramedical technician. We justify the creation of the device in 3 axes that we consider angular: 1.-Surgical BioSecurity.-Current metal surgery teams according to recent studies by the National Center for Biotechnology Information or National Center for Biotechnology Information and Journal American Medical Association can transfer B-amyloid prion proteins - Protein sequence - generate diseases in the Central Nervous System. Although the probability is very low, it exists. We want to eradicate that possibility. The device guarantees 100% not to transfer prions or amyloid proteins due to its single use condition without prior contact with blood or body fluids. - Collectively, all prion diseases raise the potential for surgical instruments to become contaminated with prions during surgical procedures. (Davanipour et al., 1985; Collins et al., 1999; Minatogawa & Kumoi, 1999; Ward et al., 2002; Mahillo -Fernandez et al., 2008), including anesthesia (Hernandez-Palazon et al., 1998) and dentistry (Smith et al., 2002; Walker et al., 2007). Accidental transmission to humans via a contaminated neurosurgical instrument has also been reported (Bernoulli et al., 1977; Gibbs et al., 1994). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081234/ 2.- Eco-friendly: it is made of biopolymers and is biodegradable. The device generates negative impact -50 gr in the generation of hospital waste. This fact makes us a start-up with a neutral balance of hospital garbage, an acronym term (B.N.B.H) that we will soon introduce in the medical academy to measure the impact of health companies that pollute. Tons of hospital waste going to the oceans and chemicals from the sterilization process can be saved. Today in World 3kg / garbage / patient / day / hospitalized are generated (https://www.minsal.cl/portal/url/item/71aa17a4d344c962e04001011f0162c8.pdf.) 3.- Visual Field. -The device emits 50-60 lumens at the incision point improving visibility in minor surgery, this data would even create a new standard since the supreme decree Chile 594 https://www.leychile.cl/Consulta/ m / norma_plana? org = & idNorma = 167766 does not regulate light on incision sites, it regulates 5,000 lumens for dental chairs and 20,000 lumens for operating room tables.
Sector / Industry{{industry.name}}
Products and Services
{{pas.productName}}
HS code: {{pas.hsCode | limitTo: 23}}
HS code: {{pas.hsCode | limitTo: 23}}
Show more
Commercial information
Main customers:
Recell Chile
Certifications:
iso 11607
This company is not yet verified
Contact this company through Start-Up Nation Central
To get in touch with the ConnectAmericas support team, please send an e-mail with your request to soporte@connectamericas.com and we will get back to you briefly.
Follow Us